Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Dow
McKesson
Farmers Insurance
Daiichi Sankyo
UBS
AstraZeneca
Cerilliant
Baxter

Generated: May 21, 2018

DrugPatentWatch Database Preview

ADAPALENE AND BENZOYL PEROXIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Adapalene And Benzoyl Peroxide patents expire, and what generic alternatives are available?

Adapalene And Benzoyl Peroxide is a drug marketed by Actavis Mid Atlantic, Perrigo Israel, and Taro. and is included in three NDAs.

The generic ingredient in ADAPALENE AND BENZOYL PEROXIDE is adapalene; benzoyl peroxide. There are twelve drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the adapalene; benzoyl peroxide profile page.
Summary for ADAPALENE AND BENZOYL PEROXIDE
US Patents:0
Applicants:3
NDAs:3
Suppliers / Packagers: 3
Clinical Trials: 161
Formulation / Manufacturing:see details
DailyMed Link:ADAPALENE AND BENZOYL PEROXIDE at DailyMed
Drug patent expirations by year for ADAPALENE AND BENZOYL PEROXIDE
Pharmacology for ADAPALENE AND BENZOYL PEROXIDE
Ingredient-typeRetinoids
Drug ClassRetinoid

US Patents and Regulatory Information for ADAPALENE AND BENZOYL PEROXIDE

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic ADAPALENE AND BENZOYL PEROXIDE adapalene; benzoyl peroxide GEL;TOPICAL 203790-001 Sep 30, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Perrigo Israel ADAPALENE AND BENZOYL PEROXIDE adapalene; benzoyl peroxide GEL;TOPICAL 205033-001 Jan 23, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Taro ADAPALENE AND BENZOYL PEROXIDE adapalene; benzoyl peroxide GEL;TOPICAL 206959-001 Jan 24, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Cipla
Deloitte
Argus Health
Farmers Insurance
Baxter
US Department of Justice
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
DrugPatentWatch reviews  
Links

Follow DrugPatentWatch: